Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$141.25
al cierre: Oct 22 EDT
$141.24
-0.01000-0.01%
Pre-comercialización: 7:59 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Lam Research Corp ha un obiettivo di prezzo di consenso pari a $214.56, stabilito in base alle ultime valutazioni degli analisti di 29. Le ultime 3 valutazioni degli analisti sono state rilasciate da Barclays, Mizuho y Stifel il octubre 20, 2025, octubre 16, 2025 y octubre 13, 2025. Con un obiettivo di prezzo medio di $146.33 tra le Barclays, Mizuho y Stifel, c'è un implicito 3.61% upside per Lam Research Corp da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Barclays
Mizuho
Stifel
Goldman Sachs
HSBC
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Lam Research
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/20/2025 | 0.54% | Barclays | $83 → $142 | Maintains | Equal-Weight | |||
10/16/2025 | 14.7% | Mizuho | $130 → $162 | Maintains | Outperform | |||
10/13/2025 | -4.42% | Stifel | $115 → $135 | Maintains | Buy | |||
10/09/2025 | 13.28% | Goldman Sachs | $115 → $160 | Maintains | Buy | |||
09/30/2025 | -10.08% | HSBC | → $127 | Initiates | → Hold | |||
09/29/2025 | 6.2% | Deutsche Bank | $100 → $150 | Upgrade | Hold → Buy | |||
09/24/2025 | 13.28% | B. Riley Securities | $130 → $160 | Maintains | Buy | |||
09/23/2025 | — | Keybanc | — | Downgrade | Overweight → Sector Weight | |||
09/22/2025 | -11.5% | Morgan Stanley | $92 → $125 | Upgrade | Underweight → Equal-Weight | |||
09/12/2025 | -7.96% | Mizuho | $120 → $130 | Maintains | Outperform | |||
09/08/2025 | -15.04% | Citigroup | $113 → $120 | Maintains | Buy | |||
09/02/2025 | -34.86% | Morgan Stanley | $94 → $92 | Downgrade | Equal-Weight → Underweight | |||
08/21/2025 | -15.04% | Cantor Fitzgerald | $115 → $120 | Maintains | Overweight | |||
08/01/2025 | -19.99% | Citigroup | $108 → $113 | Maintains | Buy | |||
08/01/2025 | -15.04% | Argus Research | $105 → $120 | Maintains | Buy | |||
08/01/2025 | -15.04% | Mizuho | $115 → $120 | Maintains | Outperform | |||
07/31/2025 | -30.61% | Wells Fargo | $95 → $98 | Maintains | Equal-Weight | |||
07/31/2025 | -18.58% | Stifel | $110 → $115 | Maintains | Buy | |||
07/31/2025 | -33.45% | Morgan Stanley | $87 → $94 | Maintains | Equal-Weight | |||
07/31/2025 | -22.12% | Raymond James | $90 → $110 | Maintains | Outperform | |||
07/31/2025 | -15.04% | Oppenheimer | $110 → $120 | Maintains | Outperform | |||
07/31/2025 | -18.58% | Needham | $110 → $115 | Maintains | Buy | |||
07/29/2025 | -22.12% | Stifel | $92 → $110 | Maintains | Buy | |||
07/28/2025 | -41.23% | Barclays | $70 → $83 | Maintains | Equal-Weight | |||
07/21/2025 | -15.04% | UBS | $95 → $120 | Maintains | Buy | |||
07/15/2025 | -18.58% | Keybanc | $105 → $115 | Maintains | Overweight | |||
07/14/2025 | -18.58% | Mizuho | $100 → $115 | Maintains | Outperform | |||
07/10/2025 | -18.58% | Goldman Sachs | → $115 | Initiates | → Buy | |||
07/08/2025 | -32.74% | Wells Fargo | $75 → $95 | Maintains | Equal-Weight | |||
07/07/2025 | -23.53% | Citigroup | $87 → $108 | Maintains | Buy | |||
07/01/2025 | -38.4% | Morgan Stanley | $82 → $87 | Maintains | Equal-Weight | |||
06/24/2025 | -18.58% | Cantor Fitzgerald | $90 → $115 | Maintains | Overweight | |||
06/18/2025 | -18.58% | B. Riley Securities | $95 → $115 | Maintains | Buy | |||
06/17/2025 | -22.12% | Oppenheimer | $80 → $110 | Maintains | Outperform | |||
04/24/2025 | -32.74% | UBS | $90 → $95 | Maintains | Buy | |||
04/24/2025 | -32.74% | JP Morgan | $110 → $95 | Maintains | Overweight | |||
04/24/2025 | -36.28% | Raymond James | $100 → $90 | Maintains | Outperform | |||
04/24/2025 | -50.44% | Deutsche Bank | $78 → $70 | Maintains | Hold | |||
04/24/2025 | -32.74% | B. Riley Securities | $90 → $95 | Maintains | Buy | |||
04/24/2025 | -43.36% | Needham | $96 → $80 | Maintains | Buy | |||
04/24/2025 | -41.94% | Morgan Stanley | $81 → $82 | Maintains | Equal-Weight | |||
04/24/2025 | -36.28% | Cantor Fitzgerald | $90 → $90 | Reiterates | Overweight → Overweight | |||
04/24/2025 | -29.2% | TD Securities | $110 → $100 | Maintains | Buy | |||
04/24/2025 | -46.9% | Wells Fargo | $85 → $75 | Maintains | Equal-Weight | |||
04/24/2025 | -29.91% | Evercore ISI Group | $95 → $99 | Maintains | Outperform | |||
04/22/2025 | -50.44% | Barclays | $75 → $70 | Maintains | Equal-Weight | |||
04/16/2025 | -36.28% | B of A Securities | $110 → $90 | Maintains | Buy | |||
04/15/2025 | -34.86% | Stifel | $100 → $92 | Maintains | Buy | |||
04/14/2025 | -36.28% | UBS | $95 → $90 | Maintains | Buy | |||
04/11/2025 | -43.36% | Oppenheimer | $95 → $80 | Maintains | Outperform | |||
03/28/2025 | -29.2% | Jefferies | $95 → $100 | Maintains | Buy | |||
03/20/2025 | -32.74% | Oppenheimer | → $95 | Initiates | → Outperform | |||
02/20/2025 | -25.66% | Keybanc | $95 → $105 | Maintains | Overweight | |||
02/20/2025 | -22.12% | B of A Securities | $100 → $110 | Maintains | Buy | |||
02/20/2025 | -11.5% | Susquehanna | $75 → $125 | Upgrade | Neutral → Positive | |||
02/20/2025 | -29.2% | Mizuho | $87 → $100 | Maintains | Outperform | |||
02/20/2025 | -29.2% | Cantor Fitzgerald | $100 → $100 | Reiterates | Overweight → Overweight | |||
02/18/2025 | -29.2% | Cantor Fitzgerald | $100 → $100 | Maintains | Overweight | |||
01/31/2025 | -44.77% | Deutsche Bank | $76 → $78 | Maintains | Hold | |||
01/30/2025 | -42.65% | Morgan Stanley | $78 → $81 | Maintains | Equal-Weight | |||
01/30/2025 | -38.4% | Mizuho | $90 → $87 | Maintains | Outperform | |||
01/30/2025 | -29.2% | Cantor Fitzgerald | $95 → $100 | Upgrade | Neutral → Overweight | |||
01/30/2025 | -39.82% | Wells Fargo | $82 → $85 | Maintains | Equal-Weight | |||
01/30/2025 | -36.28% | Needham | $90 → $90 | Reiterates | Buy → Buy | |||
01/17/2025 | -32.74% | Keybanc | $95 → $95 | Upgrade | Sector Weight → Overweight | |||
01/17/2025 | -46.9% | Barclays | $90 → $75 | Maintains | Equal-Weight | |||
01/15/2025 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
01/13/2025 | -36.28% | Needham | $100 → $90 | Maintains | Buy | |||
01/13/2025 | -41.94% | Wells Fargo | $83 → $82 | Maintains | Equal-Weight | |||
01/10/2025 | -36.28% | Mizuho | $95 → $90 | Maintains | Outperform | |||
01/10/2025 | -39.82% | Goldman Sachs | $96 → $85 | Maintains | Buy | |||
12/06/2024 | -41.23% | Wells Fargo | $85 → $83 | Maintains | Equal-Weight | |||
12/05/2024 | -44.77% | Morgan Stanley | $76 → $78 | Maintains | Equal-Weight | |||
11/29/2024 | -39.82% | Bernstein | $95 → $85 | Maintains | Market Perform | |||
10/24/2024 | -29.2% | Cantor Fitzgerald | $100 → $100 | Reiterates | Neutral → Neutral | |||
10/24/2024 | -46.19% | Morgan Stanley | $77 → $76 | Maintains | Equal-Weight | |||
10/24/2024 | -29.2% | Stifel | $105 → $100 | Reiterates | Buy → Buy | |||
10/24/2024 | -39.82% | Wells Fargo | $88 → $85 | Maintains | Equal-Weight | |||
10/24/2024 | -22.12% | B. Riley Securities | $105 → $110 | Reiterates | Buy → Buy | |||
10/24/2024 | -29.2% | Needham | $100 → $100 | Reiterates | Buy → Buy | |||
10/03/2024 | 523.05% | Wells Fargo | $1000 → $880 | Maintains | Equal-Weight | |||
09/30/2024 | 608.01% | Cantor Fitzgerald | $1200 → $1000 | Maintains | Neutral | |||
09/20/2024 | 572.61% | Mizuho | $1050 → $950 | Maintains | Outperform | |||
09/17/2024 | 448% | Morgan Stanley | $929 → $774 | Maintains | Equal-Weight | |||
09/16/2024 | 532.26% | Citigroup | $990 → $893 | Maintains | Buy | |||
09/12/2024 | 714.22% | UBS | $1250 → $1150 | Maintains | Buy | |||
08/05/2024 | 600.93% | Citigroup | $1025 → $990 | Maintains | Buy | |||
08/01/2024 | 643.42% | Mizuho | $960 → $1050 | Maintains | Outperform | |||
08/01/2024 | 643.42% | TD Cowen | $1000 → $1050 | Maintains | Buy | |||
08/01/2024 | 572.61% | Deutsche Bank | $1100 → $950 | Maintains | Buy | |||
08/01/2024 | 749.62% | Cantor Fitzgerald | $1200 → $1200 | Reiterates | Neutral → Neutral | |||
08/01/2024 | 608.01% | Wells Fargo | $1100 → $1000 | Maintains | Equal-Weight | |||
08/01/2024 | 700.06% | Needham | $1130 → $1130 | Reiterates | Buy → Buy | |||
07/16/2024 | 749.62% | Cantor Fitzgerald | $1100 → $1200 | Maintains | Neutral | |||
06/20/2024 | 838.12% | B. Riley Securities | $1130 → $1325 | Maintains | Buy | |||
06/17/2024 | 678.82% | Wells Fargo | $980 → $1100 | Maintains | Equal-Weight | |||
06/07/2024 | 650.5% | Raymond James | $950 → $1060 | Maintains | Outperform | |||
06/05/2024 | 537.21% | Barclays | $865 → $900 | Maintains | Equal-Weight | |||
05/13/2024 | 678.82% | Jefferies | $980 → $1100 | Assumes | Buy → Buy | |||
04/25/2024 | 629.26% | Needham | $1030 → $1030 | Reiterates | Buy → Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Lam Research (LRCX)?
El último precio objetivo de Lam Research (NASDAQ:LRCX) fue comunicado por Barclays el octubre 20, 2025. La firma de analistas fijó un precio objetivo para $142.00 que espera LRCX a rise dentro de 12 meses (un posible 0.54% upside). 80 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Lam Research (LRCX)?
La última calificación de analistas para Lam Research (NASDAQ:LRCX) fue proporcionada por Barclays, y Lam Research mantuvo su equal-weight calificación.
¿Cuándo se produjo la última revisión al alza de Lam Research (LRCX)?
La última revisión al alza de Lam Research Corp se produjo en septiembre 29, 2025, cuando Deutsche Bank elevó su precio objetivo a $150. Deutsche Bank anteriormente tenía a hold para Lam Research Corp.
¿Cuándo fue la última revisión a la baja de Lam Research (LRCX)?
La última revisión a la baja de Lam Research Corp se produjo en septiembre 23, 2025, cuando Keybanc cambió su precio objetivo de N/A a N/A para Lam Research Corp.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Lam Research (LRCX)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Lam Research, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Lam Research se registró el octubre 20, 2025, por lo que la próxima calificación estará disponible en torno al octubre 20, 2026.
¿Es correcta la calificación de los analistas sobre Lam Research (LRCX)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Lam Research (LRCX) fue un mantuvo con un precio objetivo de $83.00 a $142.00. El precio actual al que cotiza Lam Research (LRCX) es de $141.24, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.